APA (7th ed.) Citation

Marmé, F., Martin, M., Untch, M., Thode, C., Bonnefoi, H., Kim, S. -., . . . Loibl, S. (2024). Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: Subgroup analyses of premenopausal patients in PENELOPE-B. ESMO open, 9(6), . https://doi.org/10.1016/j.esmoop.2024.103466

Chicago Style (17th ed.) Citation

Marmé, Frederik, et al. "Palbociclib Combined with Endocrine Treatment in Hormone Receptor-positive, HER2-negative Breast Cancer Patients with High Relapse Risk After Neoadjuvant Chemotherapy: Subgroup Analyses of Premenopausal Patients in PENELOPE-B." ESMO Open 9, no. 6 (2024). https://doi.org/10.1016/j.esmoop.2024.103466.

MLA (9th ed.) Citation

Marmé, Frederik, et al. "Palbociclib Combined with Endocrine Treatment in Hormone Receptor-positive, HER2-negative Breast Cancer Patients with High Relapse Risk After Neoadjuvant Chemotherapy: Subgroup Analyses of Premenopausal Patients in PENELOPE-B." ESMO Open, vol. 9, no. 6, 2024, https://doi.org/10.1016/j.esmoop.2024.103466.